Kala Pharmaceuticals Inc logo

Kala Pharmaceuticals Inc

$ 0.31 -0.0139 (-4.29%) 09:42 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 23.71M
Enterprise V:
$ 59.48M
Volume:
40.34K
Avg Vol (2M):
1.39M
Also Trade In:
Volume:
40.34K
Market Cap $:
23.71M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.39M
Enterprise Value $:
59.48M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Kala Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
1167 Massachusetts Avenue, Arlington, MA, USA, 02476
Description
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS.
Name Current Vs Industry Vs History
Cash-To-Debt 0.56
Equity-to-Asset -0.37
Debt-to-Equity -2.53
Debt-to-EBITDA -0.63
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.99
Distress
Grey
Safe
Beneish M-Score -3.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.98
9-Day RSI 44.52
14-Day RSI 44.85
6-1 Month Momentum % -53.38
12-1 Month Momentum % -88.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.54
Quick Ratio 2.54
Cash Ratio 1.36
Days Inventory 523.34
Days Sales Outstanding 579.79
Days Payable 454.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.6

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 41.93
Operating Margin % -1307.27
Net Margin % -1628.91
ROE % -543.92
ROA % -91.75
ROIC % -242.31
ROC (Joel Greenblatt) % -833.38
ROCE % -108.98

Financials (Next Earnings Date:2022-11-15 Est.)

KALA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KALA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.395
EPS (TTM) ($) -1.96
Beta 0.67
Volatility % 147.54
14-Day RSI 44.85
14-Day ATR ($) 0.031474
20-Day SMA ($) 0.32799
12-1 Month Momentum % -88.38
52-Week Range ($) 0.281 - 3.61
Shares Outstanding (Mil) 73.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kala Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More